Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest fatty liver Stories

Old Asthma Drug Provides Benefits For Treating Diabetes, Obesity
2013-02-11 07:23:38

Lawrence LeBlond for redOrbit.com - Your Universe Online A drug that is normally prescribed for asthma patients is breathing new life as a potential treatment option for people who suffer from diabetes and obesity. The drug, amlexanox, was demonstrated to reverse obesity, diabetes and fatty liver in mice in a new study, published this week in the journal Nature Medicine. The finding comes from the research lab of Alan Saltiel, the Mary Sue Coleman director of the Life Sciences Institute...

Gene Converts Carbohydrates Into Fat
2012-12-07 05:54:07

Connie K. Ho for redOrbit.com — Your Universe Online Researchers from the University of California, Berkeley (UCB) recently discovered a gene that helps the body change carbs into fat. The team of investigators believes that the finding will be incredibly beneficial in terms of developing treatments for diabetes and fatty liver disease. In particular, the scientists at UCB looked at how the molecular mechanisms in an individual´s body can turn dietary carbohydrates into fats....

2012-11-10 08:21:34

BOSTON, Nov. 10, 2012 /PRNewswire/ -- Researchers at the University of Missouri determined that cirrhosis was not present in more than one-third of patients who had nonalcoholic fatty liver disease (NAFLD) that led to hepatocellular carcinoma (HCC). The records of 17,785 Medicare patients who had HCC were studied, and it was determined that 16 percent of those patients had NAFLD and no other way of developing cancer. About 64 percent of those patients had nonalcoholic...

2012-11-07 12:27:09

CHARLOTTESVILLE, Va., Nov. 7, 2012 /PRNewswire/ -- HemoShear LLC, a biotechnology research company and leading developer of human and animal cell-based surrogate systems for discovery and assessment of new drug compounds, will present data on its transformational liver surrogate systems at The Liver Meeting 2012, the annual meeting of the American Association for the Study of Liver Diseases (AASLD) being held in Boston, Massachusetts, on November 9-13. AASLD is the world's leading...

2012-10-31 11:26:17

BOSTON and Alexandria, Va., Oct. 31, 2012 /PRNewswire/ -- AASLD President Guadalupe Garcia-Tsao, MD, will host a press conference on the first full day of presentations at The Liver Meeting®, the annual meeting of the American Association for the Study of Liver Diseases. Dr. Garcia-Tsao will highlight individual studies and themes from the 2047 abstracts to be presented at this year's meeting from the leading researchers in the field. She has selected to review 18 abstracts in advance...

2012-09-20 16:50:12

Scientists have identified a key molecular player in a chain of events in the body that can lead to fatty liver disease, Type II diabetes and other metabolic abnormalities associated with obesity. By blocking this molecule, the researchers were able to reverse some of the pathology it caused in obese mice. Their findings appear in the Proceedings of the National Academy of Sciences. MiR-34a (pronounced MEER-34a), a micro-RNA, occurs at higher than normal levels in the livers of obese...

2012-07-25 06:35:46

By: Erika Dunayer, Ivanhoe Health Correspondent (Ivanhoe Newswire) -- Liver cancer is the third leading cancer killer worldwide. Now, researchers are working to crack the code to see what is causing it. Studies show that loss of a small RNA molecule in liver cells might cause liver cancer and that restoring the molecule might slow tumor growth and offer a new way to treat the disease. "In previous studies the microRNA-122 was very high in a normal liver but in a tumor it went down...

2012-07-04 22:46:49

Scientists at Texas Biomed have developed the laboratory opossum as a new animal model to study the most common liver disease in the nation — afflicting up to 15 million Americans — and for which there is no cure. The condition, nonalcoholic steatohepatitis (NASH), resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. The major feature of NASH is accumulation of fat in the liver, along with inflammation and functional damage. Most people with...

2012-06-22 11:32:41

An Indiana University School of Medicine gastroenterologist led a team of distinguished physicians who developed the first guidelines for diagnosis and management of non-alcoholic fatty liver disease. The guidelines were published simultaneously in the June issues of the journals Hepatology, Gastroenterology and the American Journal of Gastroenterology. Naga P. Chalasani, M.B.B.S., professor of medicine and director of the Division of Gastroenterology and Hepatology at the IU School of...

2012-06-08 09:20:09

A new study from the Virginia Commonwealth University School of Medicine has identified molecular changes responsible for abnormal cholesterol production and metabolism in the livers of patients with a common liver condition, and these changes may explain the severity of a patient's liver disease and risks to their heart health. It is estimated that a third of Americans have a fatty liver. Nonalcoholic fatty liver disease is a very common liver condition. Nonalcoholic steatohepatitis, or...